✦ LIBER ✦

Results From FAST-3: A Phase III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Subcutaneous Icatibant in Patients with Acute Hereditary Angioedema (HAE) Attacks

✍ Scribed by Lumry, W.R.; Li, H.H.; Levy, R.J.; Potter, P.C.; Farkas, H.; Reshef, A.; Moldovan, D.; Riedl, M.; Li, H.; Bloom, B.J.

Book ID: 119285163
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 42 KB
Volume: 127
Category: Article
ISSN: 1097-6825
DOI: 10.1016/j.jaci.2011.01.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Acute Abdominal and Facial

Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema (HAE) with Human C1 Esterase Inhibitor (C1-INH): Results of a Global, Multicenter, Randomized, Placebo-controlled, Phase II/III Study (I.M.P.A.C.T.1)

✍ Bernstein, J.A.; Levy, R.; Wasserman, R.L.; Bewtra, A.; Hurewitz, D.; Obtulowicz 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 42 KB

A randomised, placebo-controlled, double

A randomised, placebo-controlled, double blind phase III study of the efficacy and safety of recombinant human C1 inhibitor for the treatment of acute attacks in patients with hereditary angioedema

✍ Marco Cicardi; Roberto Perricone; Mauro Cancian; Vincenzo Montinaro; Enrico Cill 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Efficacy and safety of bifeprunox in pat

Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study

✍ Daniel E. Casey; Earl E. Sands; Jens Heisterberg; Hwa-Ming Yang 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 291 KB

950 Darbepoetin alfa significantly impro

950 Darbepoetin alfa significantly improved fatigue in patients with lymphoproliferative malignancies undergoing chemotherapy: results of a phase 3 multicenter, randomized, double-blind, placebo-controlled study

✍ H. Michael; J. Kallich; J. San Miguel; D. Watson; J. Matcham; T.J. Littlewood 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 333 KB

Impact of ustekinumab on health-related

Impact of ustekinumab on health-related quality of life in Japanese patients with moderate-to-severe plaque psoriasis: Results from a randomized, double-blind, placebo-controlled phase 2 / 3 trial

✍ Hidemi NAKAGAWA; Brad SCHENKEL; Mai KATO; Takeshi KATO; Atsuyuki IGARASHI; The J 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 French ⚖ 317 KB

Golimumab, a human anti–tumor necrosis f

Golimumab, a human anti–tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four–week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis

✍ Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Str 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views